Frequency and prognostic impact of casein kinase 1A1 mutations in MDS patients with deletion of chromosome 5q

@article{Heuser2015FrequencyAP,
  title={Frequency and prognostic impact of casein kinase 1A1 mutations in MDS patients with deletion of chromosome 5q},
  author={Michael Heuser and Manja Meggendorfer and M M Araujo Cruz and J Fabisch and Sabrina Klesse and L Koehler and Gudrun G{\"o}hring and Christina Ganster and Katayoon Shirneshan and A Gutermuth and Sabine Cerny-Reiterer and Jan Kr{\"o}nke and Victoria Panagiota and Claudia Haferlach and Christian Koenecke and Uwe- Platzbecker and Christian Thiede and Thomas A. Schr{\"o}der and Guido Kobbe and Stefan Ehrlich and Kathrin Stamer and Konstanze Doehner and Peter Valent and Brigitte Schlegelberger and Nicolaus Kr{\"o}ger and Arnold Ganser and Detlef Haase and Torsten Haferlach and Felicitas R Thol},
  journal={Leukemia},
  year={2015},
  volume={29},
  pages={1942-1945}
}
1 O'Hare T, Zabriskie MS, Eiring AM, Deininger MW. Pushing the limits of targeted therapy in chronic myeloid leukaemia. Nat Rev Cancer 2012; 12: 513–526. 2 Gorre ME, Ellwood-Yen K, Chiosis G, Rosen N, Sawyers CL. BCR-ABL point mutants isolated from patients with imatinib mesylate-resistant chronic myeloid leukemia remain sensitive to inhibitors of the BCR-ABL chaperone heat shock protein 90. Blood 2002; 100: 3041–3044. 3 Shah NP, Nicoll JM, Nagar B, Gorre ME, Paquette RL, Kuriyan J et al… CONTINUE READING
9 Citations
30 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-9 of 9 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 30 references

1A1 in the biology and targeted therapy of del(5q) MDS

  • PS Woll, U Kjallquist, O Chowdhury, H Doolittle, DC Wedge, S Thongjuea
  • Cancer Cell
  • 2014

Extended survival and reduced risk of AML progression in erythroidresponsive lenalidomidetreated patients with lowerrisk del ( 5 q ) MDS

  • AF List, JM Bennett, MA Sekeres, B Skikne, T Fu, JM Shammo
  • Leukemia
  • 2014

Role of casein kinase 1 A 1 in the biology and targeted therapy of del ( 5 q ) MDS

  • RK Schneider, V Adema, D Heckl, M Jaras, M Mallo, AM Lord
  • Cancer Cell
  • 2014

treated patients with lower-risk del(5q) MDS

  • F Thol, I Friesen, F Damm, H Yun, EM Weissinger, J Krauter
  • Leukemia
  • 2014

CKIalpha ablation highlights a critical role for p 53 in invasiveness control

  • E Elyada, A Pribluda, RE Goldstein, Y Morgenstern, G Brachya, G Cojocaru
  • Nature
  • 2011

Similar Papers

Loading similar papers…